You just read:

Canagliflozin Provided Substantial and Sustained Glycemic Improvements as Monotherapy and in Add-On Combinations in Adults with Type 2 Diabetes in Five Phase 3 Studies

News provided by

Janssen

09 Jun, 2012, 15:00 BST